Cargando…

Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell

BACKGROUND: Loss of heterozygosity (LOH) and microsatellite instability (MSI) are frequent molecular events in thyroid tumor etiopathogenesis occurring in several chromosomal critical areas, including 3p12–25.3, 7q21–31, 10q22–24, and 15q11–13, with loci of tumor suppressor genes. OBJECTIVE: We eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Migdalska-Sęk, Monika, Czarnecka, Karolina H., Kusiński, Michał, Pastuszak-Lewandoska, Dorota, Nawrot, Ewa, Kuzdak, Krzysztof, Brzeziańska-Lasota, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548761/
https://www.ncbi.nlm.nih.gov/pubmed/30747408
http://dx.doi.org/10.1007/s40291-019-00387-0
_version_ 1783423865345540096
author Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Kusiński, Michał
Pastuszak-Lewandoska, Dorota
Nawrot, Ewa
Kuzdak, Krzysztof
Brzeziańska-Lasota, Ewa
author_facet Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Kusiński, Michał
Pastuszak-Lewandoska, Dorota
Nawrot, Ewa
Kuzdak, Krzysztof
Brzeziańska-Lasota, Ewa
author_sort Migdalska-Sęk, Monika
collection PubMed
description BACKGROUND: Loss of heterozygosity (LOH) and microsatellite instability (MSI) are frequent molecular events in thyroid tumor etiopathogenesis occurring in several chromosomal critical areas, including 3p12–25.3, 7q21–31, 10q22–24, and 15q11–13, with loci of tumor suppressor genes. OBJECTIVE: We evaluated the usefulness of LOH/MSI as a diagnostic/prognostic biomarker in lesions derived from thyroid follicular cells: follicular thyroid carcinoma (FTC); follicular adenoma (FA), papillary thyroid carcinoma (PTC), and nodular goiter (NG). METHODS: We performed allelotyping (GeneMapper Software v. 4.0.) of ten microsatellite markers linked to the 1p31.2, 3p21.3, 3p24.2, 9p21.3, 11p15.5, and 16q22.1 region on DNA from 93 primary thyroid lesions then evaluated the LOH/MSI frequency and overall frequency of allelic loss (OFAL). RESULTS: We found regions with significantly increased frequency of LOH/MSI for specific histotypes: the 3p24.2 region for FA and 1p31.2 for FTC. LOH/MSI in 3p21.3 was significantly elevated in PTC and FTC. LOH/MSI in 3p21.3 was increased for small size tumors (T1a + T1b), tumors with no regional lymph node involvement (N0 + Nx), American Joint Committee on Cancer (AJCC) stage I tumors, and tumor diameter (Td) < 10 mm; in 1p31.2 for T2–3, N1, stage II–IV, and Td 10–30 mm; in 11p15.5 for T2–3, N1, stage II–IV, and Td > 30 mm. OFAL values were significantly higher in younger patients (< 40 years), in men, in those with T2–3 stage tumors, in those with increased Td, and in FA and FTC compared with NG and PTC. CONCLUSIONS: We confirmed the occurrence of LOH/MSI in 3p21.3 at an early stage of tumorigenesis and mapped 1p31.2 and 11p15.5 as characteristic for advanced-stage tumors. The results of our study may enable consideration of OFAL, defined as LOH/MSI coincidence in various chromosomal regions, as a tumor progression marker. OFAL values were significantly higher in follicular neoplasms (FA and FTC) than in PTC or NG; hence, increased OFAL values can be regarded as a characteristic feature of the follicular phenotype.
format Online
Article
Text
id pubmed-6548761
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-65487612019-06-21 Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell Migdalska-Sęk, Monika Czarnecka, Karolina H. Kusiński, Michał Pastuszak-Lewandoska, Dorota Nawrot, Ewa Kuzdak, Krzysztof Brzeziańska-Lasota, Ewa Mol Diagn Ther Original Research Article BACKGROUND: Loss of heterozygosity (LOH) and microsatellite instability (MSI) are frequent molecular events in thyroid tumor etiopathogenesis occurring in several chromosomal critical areas, including 3p12–25.3, 7q21–31, 10q22–24, and 15q11–13, with loci of tumor suppressor genes. OBJECTIVE: We evaluated the usefulness of LOH/MSI as a diagnostic/prognostic biomarker in lesions derived from thyroid follicular cells: follicular thyroid carcinoma (FTC); follicular adenoma (FA), papillary thyroid carcinoma (PTC), and nodular goiter (NG). METHODS: We performed allelotyping (GeneMapper Software v. 4.0.) of ten microsatellite markers linked to the 1p31.2, 3p21.3, 3p24.2, 9p21.3, 11p15.5, and 16q22.1 region on DNA from 93 primary thyroid lesions then evaluated the LOH/MSI frequency and overall frequency of allelic loss (OFAL). RESULTS: We found regions with significantly increased frequency of LOH/MSI for specific histotypes: the 3p24.2 region for FA and 1p31.2 for FTC. LOH/MSI in 3p21.3 was significantly elevated in PTC and FTC. LOH/MSI in 3p21.3 was increased for small size tumors (T1a + T1b), tumors with no regional lymph node involvement (N0 + Nx), American Joint Committee on Cancer (AJCC) stage I tumors, and tumor diameter (Td) < 10 mm; in 1p31.2 for T2–3, N1, stage II–IV, and Td 10–30 mm; in 11p15.5 for T2–3, N1, stage II–IV, and Td > 30 mm. OFAL values were significantly higher in younger patients (< 40 years), in men, in those with T2–3 stage tumors, in those with increased Td, and in FA and FTC compared with NG and PTC. CONCLUSIONS: We confirmed the occurrence of LOH/MSI in 3p21.3 at an early stage of tumorigenesis and mapped 1p31.2 and 11p15.5 as characteristic for advanced-stage tumors. The results of our study may enable consideration of OFAL, defined as LOH/MSI coincidence in various chromosomal regions, as a tumor progression marker. OFAL values were significantly higher in follicular neoplasms (FA and FTC) than in PTC or NG; hence, increased OFAL values can be regarded as a characteristic feature of the follicular phenotype. Springer International Publishing 2019-02-11 2019 /pmc/articles/PMC6548761/ /pubmed/30747408 http://dx.doi.org/10.1007/s40291-019-00387-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Research Article
Migdalska-Sęk, Monika
Czarnecka, Karolina H.
Kusiński, Michał
Pastuszak-Lewandoska, Dorota
Nawrot, Ewa
Kuzdak, Krzysztof
Brzeziańska-Lasota, Ewa
Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title_full Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title_fullStr Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title_full_unstemmed Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title_short Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell
title_sort clinicopathological significance of overall frequency of allelic loss (ofal) in lesions derived from thyroid follicular cell
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548761/
https://www.ncbi.nlm.nih.gov/pubmed/30747408
http://dx.doi.org/10.1007/s40291-019-00387-0
work_keys_str_mv AT migdalskasekmonika clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT czarneckakarolinah clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT kusinskimichał clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT pastuszaklewandoskadorota clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT nawrotewa clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT kuzdakkrzysztof clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell
AT brzezianskalasotaewa clinicopathologicalsignificanceofoverallfrequencyofalleliclossofalinlesionsderivedfromthyroidfollicularcell